Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIC for Cerebral Small Vessel Disease
NCT04816500Unknown
- Sponsor
- Capital Medical University
- Start
- Jan 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Capital Medical University. Primary endpoint: Changes of volume of White Matter Hyperintensities (WMHs) at 1 year. Status: unknown.
Beyond the preview
Go deeper on NCT04816500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04816500.